Literature DB >> 23725474

Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes.

Peter Calhoun1, John Lum, Roy W Beck, Craig Kollman.   

Abstract

OBJECTIVE: Knowledge of the accuracy of continuous glucose monitoring (CGM) devices is important for its use as a management tool for individuals with diabetes and for its use to assess outcomes in clinical studies. Using data from several inpatient studies, we compared the accuracy of two sensors, the Medtronic Enlite™ using MiniMed Paradigm(®) Veo™ calibration and the Sof-Sensor(®) glucose sensor using Guardian(®) REAL-Time CGM calibration (all from Medtronic Diabetes, Northridge, CA). SUBJECTS AND METHODS: Nocturnal data were analyzed from eight inpatient studies in which both CGM and reference glucose measurements were available. The analyses included 1,666 CGM-reference paired glucose values for the Enlite in 54 participants over 69 nights and 3,627 paired values for the Sof-Sensor in 66 participants over 91 nights.
RESULTS: The Enlite sensor tended to report glucose levels lower than the reference over the entire range of glucose values, whereas the Sof-Sensor values tended to be higher than reference values in the hypoglycemic range and lower than reference values in the hyperglycemic range. The overall median sensor-reference difference was -15 mg/dL for the Enlite and -1 mg/dL for the Sof-Sensor (P<0.001). The median relative absolute difference was 15% for the Enlite versus 12% for the Sof-Sensor (P=0.06); 66% of Enlite values and 73% of Sof-Sensor values met International Organization for Standardization criteria.
CONCLUSIONS: We found that the Enlite tended to be biased low over the entire glucose range, whereas the Sof-Sensor showed the more typical sensor pattern of being biased high in the hypoglycemic range and biased low in the hyperglycemic range.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725474      PMCID: PMC3757531          DOI: 10.1089/dia.2013.0042

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  14 in total

1.  Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms.

Authors:  Desmond Barry Keenan; John Joseph Mastrototaro; Howard Zisser; Kenneth A Cooper; Gautham Raghavendhar; Scott W Lee; Jonathan Yusi; Timothy S Bailey; Ronald Leonard Brazg; Rajiv V Shah
Journal:  Diabetes Technol Ther       Date:  2011-12-06       Impact factor: 6.118

2.  Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Authors:  Kerstin Rebrin; Norman F Sheppard; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  Accuracy of a new real-time continuous glucose monitoring algorithm.

Authors:  D Barry Keenan; Raymond Cartaya; John J Mastrototaro
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

4.  A bihormonal closed-loop artificial pancreas for type 1 diabetes.

Authors:  Firas H El-Khatib; Steven J Russell; David M Nathan; Robert G Sutherlin; Edward R Damiano
Journal:  Sci Transl Med       Date:  2010-04-14       Impact factor: 17.956

5.  Use of continuous glucose monitoring as an outcome measure in clinical trials.

Authors:  Roy W Beck; Peter Calhoun; Craig Kollman
Journal:  Diabetes Technol Ther       Date:  2012-10       Impact factor: 6.118

6.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Authors:  Roman Hovorka; Janet M Allen; Daniela Elleri; Ludovic J Chassin; Julie Harris; Dongyuan Xing; Craig Kollman; Tomas Hovorka; Anne Mette F Larsen; Marianna Nodale; Alessandra De Palma; Malgorzata E Wilinska; Carlo L Acerini; David B Dunger
Journal:  Lancet       Date:  2010-02-04       Impact factor: 79.321

7.  Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.

Authors:  David Rodbard; Timothy Bailey; Lois Jovanovic; Howard Zisser; Roy Kaplan; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2009-11       Impact factor: 6.118

8.  Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.

Authors:  Fraser Cameron; Darrell M Wilson; Bruce A Buckingham; Hasmik Arzumanyan; Paula Clinton; H Peter Chase; John Lum; David M Maahs; Peter M Calhoun; B Wayne Bequette
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

9.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

10.  Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas.

Authors:  Steven J Russell; Firas H El-Khatib; David M Nathan; Kendra L Magyar; John Jiang; Edward R Damiano
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

View more
  16 in total

1.  Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space.

Authors:  Lutz Heinemann; Michael Schoemaker; Günther Schmelzeisen-Redecker; Rolf Hinzmann; Adham Kassab; Guido Freckmann; Florian Reiterer; Luigi Del Re
Journal:  J Diabetes Sci Technol       Date:  2019-06-19

2.  Analysis of the Accuracy and Performance of a Continuous Glucose Monitoring Sensor Prototype: An In-Silico Study Using the UVA/PADOVA Type 1 Diabetes Simulator.

Authors:  Marc D Breton; Rolf Hinzmann; Enrique Campos-Nañez; Susan Riddle; Michael Schoemaker; Guenther Schmelzeisen-Redeker
Journal:  J Diabetes Sci Technol       Date:  2016-12-13

3.  Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.

Authors:  Tina Maria Mitre; Laurent Legault; Rémi Rabasa-Lhoret; Ahmad Haidar
Journal:  Diabetes Technol Ther       Date:  2014-01-21       Impact factor: 6.118

4.  A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.

Authors:  Viktorija Matuleviciene; Jeffrey I Joseph; Mervi Andelin; Irl B Hirsch; Stig Attvall; Aldina Pivodic; Sofia Dahlqvist; David Klonoff; Börje Haraldsson; Marcus Lind
Journal:  Diabetes Technol Ther       Date:  2014-09-18       Impact factor: 6.118

5.  Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.

Authors:  D Elleri; G Maltoni; J M Allen; M Nodale; K Kumareswaran; L Leelarathna; H Thabit; K Caldwell; M E Wilinska; P Calhoun; C Kollman; D B Dunger; Roman Hovorka
Journal:  Diabetes Obes Metab       Date:  2014-07-06       Impact factor: 6.577

6.  Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.

Authors:  Boris P Kovatchev; Stephen D Patek; Edward Andrew Ortiz; Marc D Breton
Journal:  Diabetes Technol Ther       Date:  2014-12-01       Impact factor: 6.118

7.  CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.

Authors:  Bruce Buckingham; Peiyao Cheng; Roy W Beck; Craig Kollman; Katrina J Ruedy; Stuart A Weinzimer; Robert Slover; Andrew A Bremer; John Fuqua; William Tamborlane
Journal:  Diabetologia       Date:  2015-03-14       Impact factor: 10.122

8.  Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Authors:  Darrell M Wilson; Peter M Calhoun; David M Maahs; H Peter Chase; Laurel Messer; Bruce A Buckingham; Tandy Aye; Paula K Clinton; Irene Hramiak; Craig Kollman; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2015-03-11       Impact factor: 6.118

Review 9.  Continuous Glucose Monitoring: Impact on Hypoglycemia.

Authors:  Cornelis A J van Beers; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

10.  The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.

Authors:  Monica Del Rizzo; Alfonso Galderisi; Andrea Celato; Francesca Furlan; Laura Giordano; Chiara Cazzorla; Ilaria Fasan; Carlo Moretti; Johannes Zschocke; Alberto B Burlina
Journal:  Eur J Pediatr       Date:  2016-02-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.